NR1I2 and Alzheimer disease: Rifampicin increased the mRNA level of UGT1A1 in a dose-dependent manner (Figure 4A) and accelerated the PM-induced increase in UGT1A1 in AD-like keratinocytes (Figure 4B), indicating the activation of the PXR signaling pathway.